Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.

Abstract

BACKGROUND:

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease with few therapeutic options available currently. Traditional Chinese Medicine (TCM) has been practiced for thousands of years in China and Asian countries, and regarded as an important source for identifying novel medicines for diseases. Si Miao Formula (SMF) is a classical TCM formula for the treatment of gout disease by reducing serum uric acid concentrations, while high concentration of uric acid is also an independent risk factor for NAFLD.

PURPOSE:

To investigate the protective effect of SMF on NAFLD in a mouse model induced by a high fat/high sucrose (HFHS) diet.

METHODS:

Mice received a HFHS diet over a 16-week period to induce NAFLD with or without SMF intervention. Lipid levels were measured in both the liver and serum. Histopathological staining was used to evaluate the extent of hepatic lipid accumulation. Liver transcriptomics was used to enrich differentially expressed genes and to predict regulatory pathways after gene set enrichment analysis. 16S rRNA gene sequencing was used to determine the microbial composition. Genes of liver lipid metabolism, inflammation and intestinal tight junctions were detected by qRT-PCR analysis.

RESULTS:

SMF attenuated hepatic steatosis, reduced body weight gain and lipid concentrations, improved sensitivity to insulin and also tolerance to glucose, in mice fed an HFHS diet. Hepatic transcriptomics showed that SMF downregulated the biosynthesis of fatty acids and stimulated the insulin secretion pathway. SMF significantly altered the gut microbiota composition and in particular increased the proportion of Akkermansia muciniphila. In agreement with liver transcriptomics, SMF downregulated the expression of genes implicated in the metabolism of lipids (Acly, Fas, Acc, Scd-1) and pro-inflammatory cytokines (Il-1β, Nlrp-3) in the livers.

CONCLUSION:

The results indicate that SMF attenuates HFHS diet-induced NAFLD and regulates hepatic lipid metabolism pathways. The anti-NAFLD effect of SMF was linked to modulation of the gut microbiota composition and in particular an increased relative abundance of Akkermansia muciniphila.

• Authors: Ruiting Han, Huihui Qiu, Jing Zhong, Ningning Zheng, Bingbing Li, Ying Hong, Junli Ma, Gaosong Wu, Linlin Chen, Lili Sheng, Houkai Li
• Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology (Phytomedicine) Vol. 85 Pg. 153544 (May 2021) ISSN: 1618-095X [Electronic] Germany
• PMID: 33773192 (Publication Type: Journal Article)
• Copyright: Copyright © 2021 Elsevier GmbH. All rights reserved.

Chemical References

• Drugs, Chinese Herbal
• Insulin
• Lipids
• Plant Extracts
• RNA, Ribosomal, 16S
• Uric Acid

Topics

• Animals
• Diet, High-Fat
• Drugs, Chinese Herbal (therapeutic use)
• Gastrointestinal Microbiome (drug effects)
• Inflammation (metabolism)
• Insulin (metabolism)
• Insulin Resistance
• Intestines (drug effects)
• Lipid Metabolism
• Lipids (blood)
• Liver (drug effects)
• Male
• Medicine, Chinese Traditional
• Mice
• Mice, Inbred C57BL
• Non-alcoholic Fatty Liver Disease (drug therapy)
• Plant Extracts (therapeutic use)
• RNA, Ribosomal, 16S
• Tight Junctions
• Uric Acid (metabolism)
• Weight Gain